Annual report
4323.TEDINET S100O9T8
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥18.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥18.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥867m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥785m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥965m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥579m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥31m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥318m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥579m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥583m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥15.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥12.9bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥13.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.6bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥12.3bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.3bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.0bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.2bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.9bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.8bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥417m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥643m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥87m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥527m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥147m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥185m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥39m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥224.65 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.95 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.58 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.36 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥107.9 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,493.72 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,265.96 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,154.07 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,202.34 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,181.54 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.0% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 16.7% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.5% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,448 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,320 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,164 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,111 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 920 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥17.1bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥15.2bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥14.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.8bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.7bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥780m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥699m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥731m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥1000m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥401m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥22m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥330m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥496m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥14.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥11.8bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥12.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.1bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.2bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥4.9bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.8bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.9bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.5bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥6.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.3bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.2bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥168.78 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.83 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.07 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.96 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.46 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥74.79 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,435.85 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,280.62 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,219.41 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,242.82 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,208.95 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 63.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,209,230 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 871 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 827 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 753 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 712 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 689 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 84
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥81m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥81m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | ¥2m |
| Gakuen Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥20m |
| Gakuen Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥23m |
| Gakuen Businessreportable segment | employees | at 2022-03-31 | 165 pure |
| Gakuen Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Gakuen Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Gakuen Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥6m |
| Gakuen Businessreportable segment | segment assets | at 2022-03-31 | ¥2.9bn |
| Gakuen Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Medical Big Data Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥13m |
| Medical Big Data Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Medical Big Data Businessreportable segment | employees | at 2022-03-31 | 95 pure |
| Medical Big Data Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Medical Big Data Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Medical Big Data Businessreportable segment | segment assets | at 2022-03-31 | ¥1.3bn |
| Medical Big Data Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥245m |
| Software Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥79m |
| Software Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥120m |
| Software Businessreportable segment | employees | at 2022-03-31 | 1067 pure |
| Software Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥14.4bn |
| Software Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥14.4bn |
| Software Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥69m |
| Software Businessreportable segment | segment assets | at 2022-03-31 | ¥8.4bn |
| Software Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥585m |
| System Sales Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥588,000 |
| System Sales Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| System Sales Businessreportable segment | employees | at 2022-03-31 | 23 pure |
| System Sales Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| System Sales Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| System Sales Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥5m |
| System Sales Businessreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| System Sales Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥107m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥112m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥161m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥21.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥21.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥81m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥13.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥72m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥72m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥13m |
| Gakuen Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥22m |
| Gakuen Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥24m |
| Gakuen Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.2bn |
| Gakuen Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.2bn |
| Gakuen Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥19m |
| Gakuen Businessreportable segment | segment assets | at 2021-03-31 | ¥2.2bn |
| Gakuen Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥856m |
| Medical Big Data Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥16m |
| Medical Big Data Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥17m |
| Medical Big Data Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.4bn |
| Medical Big Data Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.4bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥13,000 |
| Medical Big Data Businessreportable segment | segment assets | at 2021-03-31 | ¥879m |
| Medical Big Data Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥91m |
| Software Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥93m |
| Software Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥139m |
| Software Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥12.7bn |
| Software Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥12.7bn |
| Software Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥39m |
| Software Businessreportable segment | segment assets | at 2021-03-31 | ¥6.9bn |
| Software Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥161m |
| System Sales Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥1m |
| System Sales Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2m |
| System Sales Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| System Sales Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| System Sales Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥15m |
| System Sales Businessreportable segment | segment assets | at 2021-03-31 | ¥1.2bn |
| System Sales Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥121m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥133m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥183m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥18.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥72m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥11.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Gakuen Businessreportable segment | employees | at 2022-03-31 | 151 pure |
| Medical Big Data Businessreportable segment | employees | at 2022-03-31 | 71 pure |
| Software Businessreportable segment | employees | at 2022-03-31 | 561 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,638
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayments of lease obligations fin cf | Prior1YearDuration | -29593000 | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -28185000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -8400000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -2800000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YearDuration | － | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYearDuration | 914768000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -151509000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -152028000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -62000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -87750000 | JPY |
| Proceeds from disposal of treasury stock fin cf | Prior1YearDuration | 28842000 | JPY |
| Proceeds from disposal of treasury stock fin cf | CurrentYearDuration | 242854000 | JPY |
| Other net fin cf | Prior1YearDuration | 5680000 | JPY |
| Other net fin cf | CurrentYearDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -1247242000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | 486858000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | -25813000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 41262000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 945440000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 1610127000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 3908254000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 4853695000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 4853695000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 6463823000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 12 | |
| Directors compensations sga | Prior1YearDuration | 270797000 | JPY |
| Directors compensations sga | CurrentYearDuration | 265302000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 1333678000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 1436314000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 167760000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 226470000 | JPY |
| Provision for directors bonuses sga | Prior1YearDuration | 61553000 | JPY |
| Provision for directors bonuses sga | CurrentYearDuration | 76705000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 2394000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 2407000 | JPY |
| Directors share based compensation expenses sga | Prior1YearDuration | 36585000 | JPY |
| Directors share based compensation expenses sga | CurrentYearDuration | 41687000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 66143000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 50984000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 399548000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 436763000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 399548000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 436763000 | JPY |
| Write downs of inventories | Prior1YearDuration | 34026000 | JPY |
| Write downs of inventories | CurrentYearDuration | 22929000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05236-000SoftwareBusinessReportableSegmentMember | 12687772000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05236-000GakuenBusinessReportableSegmentMember | 3216146000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05236-000SystemSalesBusinessReportableSegmentMember | 1465779000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1419455000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 18789152000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |